Abstract
Nasal cavity and paranasal sinus malignancies constitute only 3% of all head and neck carcinomas. Malignancies of the nasal septum are rare and comprise 9% of sinonasal malignancies. In sinonasal carcinomas, squamous cell carcinoma is the most common type of malignant tumor. Here, a 64-year-old man with a nasal septal squamous cell carcinoma is presented in the context of literature information.
References
- Dulguerov P, Jacobsen MS, Allal AS, Lehmann W, Calcaterra T. Nasal and paranasal sinus carcinoma: are we making progress? A series of 220 patients and a systematic review. Cancer 2001; 92: 3012-29.
- Echeverria-Zumarraga M, Kaiser C, Gavilani C. Nasal septal carcinoma: initial symptom of nasal septal perforation. J Laryngol Otol 1988; 102: 834-5.
- Leeman DJ, Shuler KJ, Han K, Mirani N. Dedifferentiation of primary squamous cell carcinoma arising from the nasal septum. Otolaryngol Head Neck Surg 1996; 114: 131-6.
- Zheng W, McLaughlin JK, Chow WH, Chien HT, Blot WJ. Risk factors for cancers of the nasal cavity and paranasal sinuses among white men in the United States. Am J Epidemiol 1993; 138: 965-72.
- Beatty CW, Pearson BW, Kern EB. Carcinoma of the nasal septum: experience with 85 cases. Otolaryngol Head Neck Surg 1982; 90: 90-4.
- Fradis M, Podoshin L, Gertner R, Sabo E. Squamous cell carcinoma of the nasal septum mucosa. Ear Nose Throat J 1993; 72: 217-21.
- Kızıklkaya Z, Emir H, Ceylan K, Samim E. Nazal septumun primer yassı hücreli karsinomu. Türkiye Klinikleri J Med Sci 2008; 28: 977-9.
- Ho YM, Coman WB. Nasal septum malignancy. ANZ J Surg 2011; 81: 533-6.
- Lund VJ. Malignant tumours of the nasal cavity and paranasal sinuses. ORL J Otorhinolaryngol Relat Spec 1983; 45: 1-12.
- LeLiever WC, Bailey BJ, Griffiths C. Carcinoma of the nasal septum. Arch Otolaryngol 1984; 110: 748-51.
Details
| Primary Language | English |
|---|---|
| Subjects | Otorhinolaryngology |
| Journal Section | Case Report |
| Authors | |
| Publication Date | April 1, 2018 |
| Published in Issue | Year 2018 Volume: 1 Issue: 1 |
Cite
You can find the current version of the Instructions to Authors at: https://www.eurjrhinol.org/en/instructions-to-authors-104
Starting on 2020, all content published in the journal is licensed under the Creative Commons Attribution-NonCommercial (CC BY-NC) 4.0 International
License which allows third parties to use the content for non-commercial purposes as long as they give credit to the original work. This license
allows for the content to be shared and adapted for non-commercial purposes, promoting the dissemination and use of the research published in
the journal.
The content published before 2020 was licensed under a traditional copyright, but the archive is still available for free access.